|
|
|
Insider
Information: |
Bentsur Ron |
Relationship: |
Chairman & CEO, Direct... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
4,184,530 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$50,755 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
4,184,530 |
|
|
Total
Value |
$50,755 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Keryx Biopharmaceuticals Inc |
KERX |
Chief Executive Office... |
2015-04-06 |
777,209 |
|
0 |
Premium* |
|
XTL Biopharmaceuticals Ltd |
XTLBY |
CEO |
2007-08-21 |
20,101 |
|
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Director |
2020-06-10 |
0 |
|
0 |
Premium* |
|
Beyond Air Ord Shs |
XAIR |
Director |
2023-03-20 |
144,736 |
|
0 |
Premium* |
|
Nuvectis Pharma, Inc. |
NVCT |
Chairman & CEO, Direct... |
2024-03-18 |
3,242,484 |
2022-02-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
150 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KERX |
Keryx Biopharmaceuticals ... |
officerTitle |
|
2003-06-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,491 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Accounting Officer |
|
2006-03-29 |
4 |
S |
$18.78 |
$658,376 |
D/D |
(35,000) |
14,991 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Accounting Officer |
|
2006-03-29 |
4 |
OE |
$1.10 |
$38,500 |
D/D |
35,000 |
49,991 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
CEOOfficer |
|
2009-05-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
206,661 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2009-05-22 |
4 |
B |
$0.37 |
$29,767 |
D/D |
80,000 |
286,661 |
2.74 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2009-06-23 |
4 |
B |
$0.90 |
$4,997 |
D/D |
5,560 |
292,221 |
2.73 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2009-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
392,221 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2010-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
642,221 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2010-03-24 |
4 |
S |
$2.95 |
$91,713 |
D/D |
(31,089) |
611,132 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2010-12-02 |
4 |
S |
$5.05 |
$1,038,078 |
D/D |
(205,560) |
405,572 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2010-12-03 |
4 |
S |
$5.01 |
$250,500 |
D/D |
(50,000) |
355,572 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2011-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
380,572 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2011-03-24 |
4 |
S |
$4.78 |
$137,621 |
D/D |
(28,791) |
351,781 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2011-08-10 |
4 |
B |
$3.05 |
$22,905 |
D/D |
7,500 |
359,281 |
2.81 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2012-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
392,281 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2012-01-03 |
4 |
S |
$2.63 |
$8,676 |
D/D |
(3,305) |
388,976 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2012-04-18 |
4 |
B |
$1.29 |
$24,773 |
D/D |
19,100 |
479,476 |
2.81 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2012-07-03 |
4 |
S |
$1.99 |
$1,361 |
D/D |
(684) |
478,792 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2012-10-03 |
4 |
S |
$2.72 |
$2,029 |
D/D |
(746) |
478,046 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
503,046 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-01-04 |
4 |
S |
$2.74 |
$16,467 |
D/D |
(6,010) |
497,036 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-03-27 |
4 |
S |
$6.88 |
$214,869 |
D/D |
(31,231) |
465,805 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-04-05 |
4 |
S |
$6.93 |
$12,439 |
D/D |
(1,795) |
464,010 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-07-05 |
4 |
S |
$7.95 |
$19,398 |
D/D |
(2,440) |
461,570 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-10-03 |
4 |
S |
$10.25 |
$25,676 |
D/D |
(2,505) |
459,065 |
0 |
- |
|
150 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|